Safety and activity of the pan-fibroblast growth factor receptor (FGFR
- This topic has 0 replies, 1 voice, and was last updated 7 years, 2 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Safety and activity of the pan-fibroblast growth factor receptor (FGFR) inhibitor erdafitinib in phase 1 study patients (Pts) with molecularly selected advanced cholangiocarcinoma (CCA).
http://abstracts.asco.org/199/AbstView_199_185933.html
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.